Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS
Eur J Endocrinol 130 : 224228 Bengtsson BA et al
[DOI] [PMC free article] [PubMed] [Google Scholar] Neumann J
Why Perfect B Is Evaluating AOD 9604: Our Clinical Perspective We began our internal evaluation of AOD 9604 in response to a consistent pattern we were seeing with patients in our South Florida practice: people who had experienced meaningful fat loss on GLP-1 medications, then plateaued or discontinued due to side effects, and were looking for a next option
BPC-157 should not replace conventional medical treatment for serious gastrointestinal conditions
Clinicians may monitor complete blood counts, vitamin B12 levels, methylmalonic acid, homocysteine, potassium, or other markers depending on the situation